Glaxo's $5 Billion Takeover of Tesaro Seen as Too Expensive
A logo sits on a metal security gate outside GlaxoSmithKline Plc’s headquarters in London, U.K. (Photographer: Chris Ratcliffe/Bloomberg)

Glaxo's $5 Billion Takeover of Tesaro Seen as Too Expensive

(Bloomberg) -- GlaxoSmithKline Plc Chief Executive Officer Emma Walmsley bolstered a thin roster of new treatments by agreeing to buy drugmaker Tesaro Inc. for $5.1 billion, gaining a foothold in t...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.